BioCentury
ARTICLE | Clinical News

IPL455: Phase IIa started

March 6, 2006 8:00 AM UTC

The partners started a 4-week, double-blind, placebo-controlled, European Phase IIa trial in about 75 patients with age-associated memory impairment. ...